Global Blood Therapeutics - Business-News-Today.com

🚀 Building a website? Start with reliable WordPress hosting from MilesWeb →

Business news, market intelligence, and global industry analysis.

The Latest

GoldStone Resources (AIM: GRL) shares jump as Persistence Gold takes 21% stake in AIM miner

Nexsen (ASX: NXN) jumps as StrepSure validation path sharpens

Novartis agrees $1.5bn Myricx Bio deal as ADC platform race intensifies

Knights Group revenue jumps 28% as KGH organic growth accelerates to 12%

Read More

Pharma Industry News

Pfizer to acquire Oxbryta developer Global Blood Therapeutics for $5.4bn

Pfizer has agreed to acquire Global Blood Therapeutics (GBT), a publicly-listed American biopharma company, in a deal worth…

August 8, 2022

Read More

Pharma Industry News

Global Blood Therapeutics bags Oxbryta FDA approval for sickle cell disease

Oxbryta FDA approval : Global Blood Therapeutics (GBT), a California-based biopharma company, has bagged approval for Oxbryta (voxelotor)…

bypharmanewsdaily

November 27, 2019

web analytics